454 related articles for article (PubMed ID: 30700697)
1. Cell death pathways in pathogenic trypanosomatids: lessons of (over)kill.
Menna-Barreto RFS
Cell Death Dis; 2019 Jan; 10(2):93. PubMed ID: 30700697
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi.
Parsons M; Worthey EA; Ward PN; Mottram JC
BMC Genomics; 2005 Sep; 6():127. PubMed ID: 16164760
[TBL] [Abstract][Full Text] [Related]
3. The ultimate fate determinants of drug induced cell-death mechanisms in Trypanosomatids.
Das P; Saha S; BoseDasgupta S
Int J Parasitol Drugs Drug Resist; 2021 Apr; 15():81-91. PubMed ID: 33601284
[TBL] [Abstract][Full Text] [Related]
4. Naphthoquinones and Derivatives for Chemotherapy: Perspectives and Limitations of their Anti-trypanosomatids Activities.
Dantas-Pereira L; Cunha-Junior EF; Andrade-Neto VV; Bower JF; Jardim GAM; da Silva Júnior EN; Torres-Santos EC; Menna-Barreto RFS
Curr Pharm Des; 2021; 27(15):1807-1824. PubMed ID: 33167829
[TBL] [Abstract][Full Text] [Related]
5. The double-edged sword in pathogenic trypanosomatids: the pivotal role of mitochondria in oxidative stress and bioenergetics.
Menna-Barreto RF; de Castro SL
Biomed Res Int; 2014; 2014():614014. PubMed ID: 24800243
[TBL] [Abstract][Full Text] [Related]
6. Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review.
Benaim B; Garcia CR
Trop Biomed; 2011 Dec; 28(3):471-81. PubMed ID: 22433874
[TBL] [Abstract][Full Text] [Related]
7. Unveiling the intracellular survival gene kit of trypanosomatid parasites.
Bartholomeu DC; de Paiva RM; Mendes TA; DaRocha WD; Teixeira SM
PLoS Pathog; 2014 Dec; 10(12):e1004399. PubMed ID: 25474314
[TBL] [Abstract][Full Text] [Related]
8. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
[TBL] [Abstract][Full Text] [Related]
9. Signal Transduction Pathways as Therapeutic Target for Chagas Disease.
Schoijet AC; Sternlieb T; Alonso GD
Curr Med Chem; 2019; 26(36):6572-6589. PubMed ID: 31218950
[TBL] [Abstract][Full Text] [Related]
10. Transient Superdiffusion and Long-Range Correlations in the Motility Patterns of Trypanosomatid Flagellate Protozoa.
Alves LG; Scariot DB; Guimarães RR; Nakamura CV; Mendes RS; Ribeiro HV
PLoS One; 2016; 11(3):e0152092. PubMed ID: 27007779
[TBL] [Abstract][Full Text] [Related]
11. The superfamily keeps growing: Identification in trypanosomatids of RibJ, the first riboflavin transporter family in protists.
Balcazar DE; Vanrell MC; Romano PS; Pereira CA; Goldbaum FA; Bonomi HR; Carrillo C
PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005513. PubMed ID: 28406895
[TBL] [Abstract][Full Text] [Related]
12. Searching the Tritryp genomes for drug targets.
Myler PJ
Adv Exp Med Biol; 2008; 625():133-40. PubMed ID: 18365664
[TBL] [Abstract][Full Text] [Related]
13. Identification of Novel Chemical Scaffolds Inhibiting Trypanothione Synthetase from Pathogenic Trypanosomatids.
Benítez D; Medeiros A; Fiestas L; Panozzo-Zenere EA; Maiwald F; Prousis KC; Roussaki M; Calogeropoulou T; Detsi A; Jaeger T; Šarlauskas J; Peterlin Mašič L; Kunick C; Labadie GR; Flohé L; Comini MA
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004617. PubMed ID: 27070550
[TBL] [Abstract][Full Text] [Related]
14. Comparative Analysis of Virulence Mechanisms of Trypanosomatids Pathogenic to Humans.
de Castro Neto AL; da Silveira JF; Mortara RA
Front Cell Infect Microbiol; 2021; 11():669079. PubMed ID: 33937106
[No Abstract] [Full Text] [Related]
15. The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp.
Scarim CB; Chelucci RC; Dos Santos JL; Chin CM
Med Chem; 2020; 16(1):24-38. PubMed ID: 31218962
[TBL] [Abstract][Full Text] [Related]
16. Programmed cell death in trypanosomatids: is it an altruistic mechanism for survival of the fittest?
Debrabant A; Nakhasi H
Kinetoplastid Biol Dis; 2003 Jun; 2(1):7. PubMed ID: 12848897
[TBL] [Abstract][Full Text] [Related]
17. Is the mitochondrion a promising drug target in trypanosomatids?
Pedra-Rezende Y; Bombaça ACS; Menna-Barreto RFS
Mem Inst Oswaldo Cruz; 2022; 117():e210379. PubMed ID: 35195164
[TBL] [Abstract][Full Text] [Related]
18. Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis.
Alcântara LM; Ferreira TCS; Gadelha FR; Miguel DC
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):430-439. PubMed ID: 30293058
[TBL] [Abstract][Full Text] [Related]
19. Chemical Cartography Approaches to Study Trypanosomatid Infection.
Dean DA; Haffner JJ; Katemauswa M; McCall LI
J Vis Exp; 2022 Jan; (179):. PubMed ID: 35129167
[TBL] [Abstract][Full Text] [Related]
20. The TryPIKinome of five human pathogenic trypanosomatids: Trypanosoma brucei, Trypanosoma cruzi, Leishmania major, Leishmania braziliensis and Leishmania infantum--new tools for designing specific inhibitors.
Bahia D; Oliveira LM; Lima FM; Oliveira P; Silveira JF; Mortara RA; Ruiz JC
Biochem Biophys Res Commun; 2009 Dec; 390(3):963-70. PubMed ID: 19852933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
